• Catalog Number:

  E1A0286C-3

• Amount:

  100ul

• Form of Antibody:

  Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

• Storage/Stability:

  Store at -20℃/1 year

• class="eg_cn_title"Immunogen:

  The antiserum was produced against synthesized peptide derived from human p14 ARF antibody.

• Purification:

  The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

• Reactivity:

  Human

• SwissProtNo:

  Q8N726

• Applications:

  WB: 1:500~1:1000 IHC: 1:50~1:100 IF: 1:100~1:500 ELISA: 1:5000

• Alter Name:

  CDK4I, CMM2, MLM, MTS1, TP16; p16(INK4), p19, CDK4 inhibitor p16-INK4, alternative reading frame p14, cell cycle negative regulator beta, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), cyclin-dependent kinase inhibitor 2A isoform 1, cyclin-dependent kinase inhibitor 2A isoform 3, cyclin-dependent kinase inhibitor 2A, p14ARF, cyclin-dependent kinase inhibitor p12, p16INK4a alternatively spliced form, cyclin-dependent kinase inhibitor p16, multiple tumor suppressor 1, p16(INK4A) p14(ARF)

• Specificity Sensitivity:

  p14 ARF antibody detects endogenous levels of total p14 ARF protein.

• References:

  Béatrice Eymin, Mol. Cell. Biol., Jun 2006; 26: 4339 - 4350. Guillaume Normand, J. Biol. Chem., Feb 2005; 280: 7118 - 7130. Abel Sánchez-Aguilera, Blood, Feb 2002; 99: 1411 - 1418. Manel Esteller, Cancer Res., Apr 2001; 61: 2816 - 2821.

Peptide - + Immunohistochemical analysis of paraffin-embedded human placenta tissue using p14 ARF antibody (#C0286).

Western blot analysis of extracts from HeLa cells, using p14 ARF antibody (#C0286).

Peptide - + Immunofluorescence analysis of HeLa cells, using p14 ARF antibody (#C0286).